Excited to share our new report on SDHA! #hereditarycancer #familialparagangliomasyndrome #cancergenetics. Check it out here: ascopubs.org/doi/pdf/10.120… Colin Pritchard 👩🏻‍⚕️🧬🏩.

A fabulous group of #HereditaryGICancer leaders who, together with our members, have shaped #CGAIGC into the impactful society it is.

We must hold oncologists treating colorectal cancer to the same biomarker testing standards that we would expect in mgmt of breast cancer It is UNACCEPTABLE to treat mCRC without knowing: ✅ kras/nras/braf ✅ MMR/MSI ✅ her2 Yet fewer than 2/3rds of patients get this testing!

Day 3 of #InSiGHT2024 Aung Ko Win presents extensive data on lifestyle risk factors of CRC for individuals with #lynchsyndrome Perhaps this can direct further individualized care and management! InSiGHT

Universal testing for all #gastriccancer patients? Ophir Gilad presents our study that showed 13% of GC patients carry a PV in a cancer predisposition gene, most in HR genes and CDH1. A lot of CHEK2 I157T as well Sonia Kupfer Invitae Ed Esplin, MD, PhD #InSiGHT2024 InSiGHT

#Universal #germline #genetictesting for all #patients w/ #cancer c/w ascopubs.org/doi/10.1200/PO… JCO Precision Oncology Invitae Heather Hampel Huma Rana, MD, MPH Jewel Samadder judy garber #access #reducedisparities #germlinetesting #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention

👍study Ed Esplin, MD, PhD "Universal #genetictesting detected more clinically actionable variants than a guideline-based approach, with a significant association w/ clinical management for the patients & their families." #HereditaryGICancer

Cohort study including 660k+ women with unilateral breast cancer and followed up for 20 years found that bilateral mastectomy was associated with a statistically significant reduction of contralateral breast cancer risk but not breast cancer mortality. ja.ma/46BmJJT

Join me for the 4th precision oncology summit in San Francisco! Amazing talks, great science, multidisciplinary collaboration. See you there. Register here: education.binayfoundation.org/content/4th-bi…

Proud to be part of this large global study on young BRCA carriers with breast cancer Lobular tumors ⬆️ grade 1/2 (58% vs. 22%), stage III (30% vs. 18%), and luminal A-like (42% vs. 12%), and linked to BRCA2 (71%) No sig diff in DFS or OS compared to IDC OncoAlert

Congratulations to Nazli Dizman Ziad Bakouny, MD, MSc Toni Choueiri, MD & the entire team for this excellent work! Incredibly grateful to be part of the IMG Oncologists team, sharing my #IMG story at the ASCO #IMG CoP annual meeting & working to alleviate the struggles of #IMGs. JCO Oncology Practice

A packed room with amazing discussions on the hot topics: LA NSCLC - surgery or RT; mesothelioma - surgery or not; and more to come: Frontline EGFR/No actionable alterations: More or Less is better? #SeattleLung24

Most viewed in the last 7 days from JAMA Oncology: In a study of over 4,500 cancer patients, those who quit smoking within 6 months of diagnosis through a cessation program showed the greatest survival benefit. ja.ma/3UHnBri

'Risks of #ColorectalCancer Among #TP53 Mutation Carriers' #DrStephenGruber City of Hope CGA-IGC #CGAIGC24 #INSPIRE trial - #universal #germline #genetictesting in all #patients w/ #cancer, >20,000 enrolled to date, Heather Hampel Stacy W. Gray Found #LFS in ~1% of unselected

My pleasure. It was so nice to talk about hereditary Gi cancers and life. Love CGA-IGC #CGAIGC24 👩🏻‍⚕️🏩🧬

This list will need to grow for each cancer type. I imagine there are dozens more genes in organ-specific pathways that are critical to cancer growth, immune protection, vascular development and more. #cancergenetics 👩🏻‍⚕️🏩🧬

#Lynchsyndrome (LS) figures from the All of Us population-based study: -1/354 individuals have LS -Prevalence is higher for MSH6 / PMS2 pathogenic variants vs. MLH1 /MSH2 -Up to 63% of carriers have no personal or family history of LS-associated cancers nature.com/articles/s4146…

There is still time to register for the Natera Oncology x #CGAIGC webinar happening next week‼️ 🗓️Wednesday, February 12th, 2025 ⏱️7:00 PM ET | 4:00 PM PT ➡️Register here 👉tinyurl.com/mvsvpytp Leveraging ctDNA to enhance identification of #HereditaryGICancer will be

I just saw Aparna Raj Parikh tweet where she shares that 7 of her patients today were under 50 years old‼️ I hope they were coming for their first #colonoscopy & all is fine. Fight Colorectal Cancer state in their tweet 👇 that by 2030 #CRC will take more lives of 🧑‍🤝‍🧑 under 50 than any other

📢For #BlackHistoryMonth, we are highlighting BlackInGenetics, an organization “dedicated to amplifying the voices and work of Black-identifying geneticists across the U.S” ➡️Learn more 👉blackingenetics.com #AdvancingCommitments #HereditaryGICancer Yvonne Cardona Saldaña Lauren Giannetti Sferrazza MS, LGC